Table 4.

Top 25 Genes Differentially Expressed between AML Patients Who Lived or Died After Treatment

Gene description Probe Z-score P-value[ii] t-test[iii] W. r.s.3 Locus[iv] Locus anomalies observed in AML
Alpha IV collagen D17391 −5.96<0.00011.00001.00002q35-q37Rearrangement (Berger et al. 1991), ring  formation (Whang-Peng et al. 1987)
Integrin beta-5 subunit X53002 5.240.00111.00001.00003 (q22?)Inversion, translocation (Testoni et al. 1999)
Pyrroline-5-carboxylate  synthetase X94453 5.000.00411.00001.000010q24.3Translocation in CML (Aguiar et al. 1997),  hotspot for translocations in ALL (Kagan  et al. 1989; Salvati et al. 1999)
Alpha-tubulin X01703 4.960.00511.00001.00002q?, Rearrangement (Berger et al. 1991),  ring formation (Whang-Peng et al. 1987)
KIAA0076 D38548 −4.840.00921.00001.00006 (p12-21?)Rearrangement (Raynaud et al. 1994;  Haase et al. 1995)
Cockayne syndrome  complementation  group A U28413 4.740.01471.00001.00005 (q13?)5q11-31 frequently lost in AML (Shipley  et al. 1996;Van den Berghe and  Michaux 1997)
Set M93651 4.730.01581.00001.00009q34Translocation, may create Set-Can fusion  (von Lindern et al. 1992)
KIAA0172 D79994 −4.630.02541.00001.00009 (p?)9p abnormalities are common in leukemia  and other cancers (Ragione and Iolascon  1997)
Selenophosphate  synthetase 2  (SPS2) U43286 4.610.02851.00001.0000(16p or 10q)?Inversions and translocations are common  in 16p (Marlton et al. 1995; Mancini et  al. 2000), CML/ALL translocations  identified in 10q (Kagan et al. 1989;  Aguiar et al. 1997; Salvati et al. 1999)
Centromere  protein E  (312kD) Z15005 −4.600.02931.00001.00004q24-q254q25 translocation in ALL (Nowell et al.  1986)
Thioredoxin X77584 4.540.03921.00001.00009q31Loss (Shipley et al. 1996)
PIG-B D42138 −4.530.04091.00001.000015q21-q2215q observed deleted or translocated  (Gogineni et al. 1997; Grimwade et al.  1997)
Survival motor  neuron protein  SMN U80017 4.320.10881.00001.00005q135q11-31 frequently lost in AML (Shipley  et al. 1996; Van den Berghe and  Michaux 1997)
Caspase-8 X98176 −4.220.17551.00001.00002q33-q34Duplication in non-Hodgkin's lymphoma  (Bajalica-Lagercrantz et al. 1996), ring  formation (Whang-Peng et al. 1987)
Bullous pemphigoid  antigen M69225 −4.210.17951.00001.00006p12-p11Rearrangement (Raynaud et al. 1994;  Haase et al. 1995)
Sp2 transcription  factor D28588 −4.180.20201.00001.000017q21.3-q22Translocation spot (Melnick et al. 1999),  isochromosomes on 17q common  (Fioretos et al. 1999)
Biglycan J04599 −4.170.21191.00001.0000Xq28Translocation found in AML (Weis et al.  1985), common in ALL (Stern 1996)
26S proteasome-associated pad1  homolog (POH1) U86782 4.160.22261.00001.00002 (q24-32?)Duplication in non-Hodgkin's lymphoma  (Bajalica-Lagercrantz et al. 1996), ring  formation (Whang-Peng et al. 1987)
Homeobox-like L32606 4.140.24271.00001.0000??
Pre-mRNA splicing  factor SRP75 L14076 −4.130.25821.00001.00001 (p32-36?)1p32 and 1p36 both involved in  translocations (Selypes and Laszlo 1987;  Shimizu et al. 2000)
Autoantigen PM-SCL X66113 −4.120.26141.00001.00001p36Translocation (Shimizu et al. 2000)
Bactericidal/permeability-increasing protein J04739 4.090.30301.00001.000020q11.23-q12Deletion (commonly deleted in MDS)  (Fracchiolla et al. 1998)
HoxA9 U82759 4.040.38361.00001.00007p15-p14Inversion (Stanley et al. 1997)
Matrin 3 M63483 4.030.39401.00001.0000

[i] Dataset from Golub et al. (1999).

[ii] P-value computed from Z-score using a modified Bonferroni's correction.

[iii] P-value obtained fromtPvalue for TPO was 0.1105 and the Pvalues for the otehr genes did not change.3 P-value obtained from Wilcoxon rank sum using a modified Bonferroni's correction.

[iv] Chromosomal locus determined by survey of NCBI LocusLink (http://www.ncbi.nlm.nih.gov/LocusLink). Purative loci are shown in parentheses.